Catherine Handy Marshall, M.D., M.P.H.

Headshot of Catherine Handy Marshall
  • Assistant Professor of Oncology


Internal Medicine, Oncology

Research Interests

Prostate cancer; cancer and cardiovascular disease more

Request an Appointment

Insurance Information

Main Phone

Outside of Maryland & Washington D.C.

Request Appointment

International Patients

Request Appointment


Skip Viragh Outpatient Cancer Center

Appointment Phone: 410-955-8964
201 N. Broadway
Baltimore, MD 21287 map
Phone: 410-955-8893


Dr. Catherine Marshall is an Assistant Professor in the Department of Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include internal medicine and oncology.

She received her M.D. and M.P.H. from Johns Hopkins, where she also completed her residency and an oncology fellowship. She previously served as an Assistant Chief of Service for the Osler Medical Housestaff Training Program. more


  • Assistant Professor of Oncology

Departments / Divisions

  • Oncology - Genitourinary Cancer Disease



  • MD; Johns Hopkins University School of Medicine (2012)


  • Internal Medicine; Johns Hopkins University School of Medicine (2015)


  • Oncology; Johns Hopkins University School of Medicine (2016)
  • Oncology; Johns Hopkins University School of Medicine (2019)

Research & Publications

Research Summary

Dr. Handy Marshall's research focuses on the relationship between cardiovascular disease and cancer, clinical trials in advanced prostate cancer, and genetics in prostate cancer.

Selected Publications

View all on PubMed

Marshall CH, Fu W, Wang H, Baras AS, Lotan TL, Antonarakis ES. Prevalence of DNA repair gene mutations in localized prostate cancer according to clinical and pathologic features: association of Gleason score and tumor stage. Prostate Cancer Prostatic Dis. 2018 Aug 31. doi: 10.1038/s41391-018-0086-1. [Epub ahead of print] PubMed PMID: 30171229.

Handy CE, Quispe R, Pinto X, Blaha MJ, Blumenthal RS, Michos ED, Lima JAC, Guallar E, Ryu S, Cho J, Kaye JA, Comin-Colet J, Corbella X, Cainzos-Achirica M. Synergistic Opportunities in the Interplay Between Cancer Screening and Cardiovascular Disease Risk Assessment. Circulation. 2018 Aug 14;138(7):727-734. doi: 10.1161/CIRCULATIONAHA.118.035516. PubMed PMID: 30359131.

Handy CE, Antonarakis ES. Sipuleucel-T for the treatment of prostate cancer: novel insights and future directions. Future Oncol. 2018 Apr;14(10):907-917. doi: 10.2217/fon-2017-0531. Epub 2017 Dec 20. Review. PubMed PMID: 29260582; PubMed Central PMCID: PMC5925432.

Handy CE, Antonarakis ES. Sequencing Treatment for Castration-Resistant Prostate Cancer. Curr Treat Options Oncol. 2016 Dec;17(12):64. Review. PubMed PMID: 27822685.

Handy Marshall C, Nahas-Vigon J, Manesh R, Gelber AC. Just Beneath the Surface. N Engl J Med. 2018 Sep 6;379(10):968-973. doi: 10.1056/NEJMcps1802664. PubMed PMID: 30184453.

Activities & Honors


  • Blumenthal Award, Johns Hopkins University School of Medicine, 2015
  • Young Investigator Award, Women Who Conquer Cancer, 2017
  • Award Recipient, Stuart Scott Memorial Cancer Research Fund V Foundation, 2021
  • Young Investigator Award, Prostate Cancer Foundation, 2021

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Is this you? Edit Profile
back to top button